The medtech and biomanufacturing sectors are driving new growth in the life sciences industry. As a result, the key markets that house medtech and biomanufacturing clusters are flourishing, presenting new opportunities for commercial real estate investors and life sciences occupiers in places where science and innovation meet.
“The prospects and growth potential within the medtech and biomanufacturing sectors in relation to life sciences real estate are numerous,” said Travis McCready, head of life sciences, Americas markets, JLL. “Medical device and testing companies hold a prominent position within the life sciences industry, and biomanufacturing plays a crucial role in the lifecycle of therapeutic companies. Considering the substantial investments required and the crucial role of manufacturing operations in a company’s success, it is crucial to carefully select locations and sites that offer long-term value and optimal utilization.”
The federal government
